Edition:
United States

People: Dr.Reddy's Laboratories Ltd (RDY.N)

RDY.N on New York Stock Exchange

37.66USD
22 Sep 2017
Change (% chg)

$-0.06 (-0.16%)
Prev Close
$37.72
Open
$37.65
Day's High
$37.82
Day's Low
$37.40
Volume
94,650
Avg. Vol
81,214
52-wk High
$50.06
52-wk Low
$29.85

Iyengar, Sridar 

Mr. Sridar A. Iyengar is Non-Executive Independent Director of Dr. Reddy's Laboratories Ltd. He joined our Board in 2011. He is an independent mentor investor in early stage start-ups and companies. Earlier he was a senior partner with KPMG in the US and UK and also served as the Chairman & CEO of KPMG’s operations in India. Mr. Iyengar also holds Directorship in Rediff.com India Ltd., Mahindra Holidays and Resorts India Ltd., CL Educate Ltd., ICICI Venture Funds Management Company Ltd., Cleartrip Private Ltd., CL Media Private Limited in India; AverQ Inc., Rediff Holdings Inc. in the US; Cleartrip Inc. in Cayman Islands; Holiday Club Resorts OY in Finland and our whollyowned subsidiary, Dr. Reddy’s Laboratories S.A., in Switzerland. He holds a B.Com. (Hons.) degree from the University of Calcutta and is a Fellow member of the Institute of Chartered Accountants in England and Wales.

Basic Compensation

Total Annual Compensation, INR 10,450,000
Restricted Stock Awards, INR --
Long-Term Incentive Plans, INR --
All Other, INR --
Fiscal Year Total, INR 10,450,000

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Satish Reddy

88,030,000

G. Prasad

119,220,000

Saumen Chakraborty

39,930,000

Sripada Chandrasekhar

--

Abhijit Mukherjee

14,600,000

Amit Biswas

--
As Of  30 Mar 2016